1,25-dihydroxyvitamin D inhibits human ANP gene promoter activity
Songcang Chen1, Karl Nakamura, David G Gardner
1Diabetes Center and Department of Medicine, University of California at San Francisco, 94143-0540, USA.
Abstract:
1,25-dihydroxyvitamin D, through association with its cognate nuclear receptor, has been shown to have important effects in the cardiovascular and renal systems. We have shown previously that the liganded vitamin D receptor (VDR) inhibits hypertrophy and expression of hypertrophy-sensitive genes (i.e. those encoding atrial natriuretic peptide [ANP], brain natriuretic peptide and alpha skeletal actin) in neonatal cardiac myocytes. In the present study we confirm a time-, ligand- and retinoid X receptor-dependent, VDR-mediated suppression of human ANP gene promoter activity. Conventional deletion analysis demonstrated that the promoter region positioned between -217 and -104 is required for the VDR-dependent suppression of the hANP promoter. Mutation of two functional CArG elements, including one located within this critical region, failed to reverse the suppression. We found no evidence that the liganded VDR is capable of associating directly with regulatory elements positioned between -217 and -104. We conclude that the inhibition may arise from protein-protein interactions between the liganded VDR and stimulatory transcription factors that bind in this region.
Insights
The vitamin D receptor (VDR) suppresses the atrial natriuretic peptide (ANP) gene in heart cells. This inhibition occurs through protein interactions, not direct DNA binding, within a specific promoter region.
Area of Science:
- Cardiovascular Biology
- Molecular Endocrinology
- Gene Regulation
Background:
- 1,25-dihydroxyvitamin D and its nuclear receptor (VDR) influence cardiovascular and renal systems.
- Liganded VDR previously shown to inhibit cardiac myocyte hypertrophy and related gene expression.
Purpose of the Study:
- To confirm VDR-mediated suppression of the human ANP gene promoter.
- To identify the specific promoter region and mechanism involved in VDR-dependent suppression.
Main Methods:
- Confirmation of VDR-mediated suppression using time-, ligand-, and retinoid X receptor-dependent assays.
- Deletion analysis to pinpoint the critical promoter region (-217 to -104).
- Mutation analysis of CArG elements within the promoter region.
Main Results:
- VDR-dependent suppression of the human ANP gene promoter was confirmed.
- A promoter region between -217 and -104 was essential for VDR-mediated suppression.
- Mutation of CArG elements did not abolish the suppression effect.
- Direct binding of liganded VDR to the -217 to -104 region was not observed.
Conclusions:
- VDR-mediated suppression of the ANP gene promoter is confirmed.
- The critical regulatory region for VDR suppression is located between -217 and -104.
- VDR likely inhibits ANP gene expression through protein-protein interactions with transcription factors, rather than direct DNA binding.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Related Concept Videos
Cell Specific Gene Expression
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Angiogenesis and Blood Supply
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
